REV
Recent news mentioning REV
- — Nuix amplía la IA generativa para la revisión legal y presenta un chat con IA para datos de casos
- — Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS
- — Hagens Berman Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to FDA Review Extension for Deramiocel Amid Ongoing Securities Class Action and September 28 Lead Plaintiff Deadline
- — Banche centrali, la previsione di Ing su Fed, Bce, BoE e BoJ di settembre 2026
- — OHLA pide una dispensa a acreedores tras el revés de 26 millones en Catar
- — WINFARM : 2026 H1 revenues.
- — Analyst reveals 'easy' Bitcoin target of $1.3 million
- — Trump Envoys Shuttle Between Moscow and Kyiv as U.S. Revives Ukraine Peace Push
- — Tempo e prevedibilità: il ruolo degli investimenti a rendimento definito nel lungo termine
- — Canopy Growth's Revenue Grew 13% Last Quarter. Investors Barely Reacted. Here's Why.
- — ASIC reviews misconduct cases involving ‘Big Four’ operators
- — Genesco raises FY27 profit target despite revenue slump